NCT02344810 2023-05-25
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
Eastern Cooperative Oncology Group
Phase 1/2 Withdrawn
Clinical Trials
7 trialsNCT03982173 2023-01-26
MATILDA
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Withdrawn
NCT03592407 2022-03-08
Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer
City of Hope Medical Center
Phase 2 Withdrawn
NCT05001360 2021-10-27
Study of FMT Combined With Nivolumab in Gastric Cancer
Fujian Cancer Hospital
Phase NA Withdrawn
NCT00372450 2019-03-20
Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Withdrawn
NCT03307941 2017-12-19
ARTEMIS-Eso
Jules Bordet Institute
Phase 1/2 Withdrawn
NCT00025532 2012-09-14
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer
University of California, San Francisco
Phase 1 Withdrawn